In this issue:
IL-17 vs IL-23 inhibitors in pustular and erythrodermic psoriasis
Risk of infection in paediatric recipients of ustekinumab, etanercept, or methotrexate
Bimekizumab switched from adalimumab, ustekinumab or secukinumab
Long-term follow-up in new-onset guttate psoriasis
Higher prevalence of generalised pustular psoriasis in Asia
Orismilast for moderate-to-severe psoriasis
Drug utilisation in Italian patients with psoriasis
Patient preference for calcipotriene and betamethasone dipropionate cream vs foam
Epidemiological relationship between vitiligo and psoriasis
Please login below to download this issue (PDF)